article Open AccessTop 10% cited
Development and Validation of an Abbreviated Version of the Expanded Prostate Cancer Index Composite Instrument for Measuring Health-related Quality of Life Among Prostate Cancer Survivors
Urology · 2010 · Vol. 76(5) · pp. 1245–1250
Konrad Szymañski(Beth Israel Deaconess Medical Center)John T. Wei(University of Michigan–Ann Arbor)Rodney L. Dunn(University of Michigan–Ann Arbor)Martin G. Sanda✉(Beth Israel Deaconess Medical Center)
Prostate Cancer Diagnosis and TreatmentHealth and Wellbeing ResearchHealth Systems, Economic Evaluations, Quality of LifeMedicineProstate cancerQuality of life (healthcare)CancerHealth related quality of lifeProstateIndex (typography)OncologyInternal medicineDisease
MeSH terms
Health StatusHumansMaleProstatectomyProstatic NeoplasmsQuality of LifeSurveys and QuestionnairesSurvivors
Funding
- National Institutes of Health
Citations
457
FWCI
8.18
field-weighted impact
References
20
Percentile
98%
vs. same field & year
Citations per year
References
The UCLA Prostate Cancer Index
Medical Care · 1998 · 835 citations
Measuring quality of life in men with prostate cancer using the Functional Assessment of Cancer Therapy-prostate instrument
Urology · 1997 · 686 citations
The Functional Assessment of Cancer Therapy scale: development and validation of the general measure.
Journal of Clinical Oncology · 1993 · 5,962 citations
Development and validation of the expanded prostate cancer index composite (EPIC) for comprehensive assessment of health-related quality of life in men with prostate cancer
Urology · 2000 · 1,500 citations
A 12-Item Short-Form Health Survey
Medical Care · 1996 · 16,925 citations
The American Urological Association Symptom Index for Benign Prostatic Hyperplasia
The Journal of Urology · 2016 · 1,939 citations
The American Urological Association Symptom Index for Benign Prostatic Hyperplasia
The Journal of Urology · 1992 · 3,397 citations
Citation Network
How this paper connects to the literature. Drag to explore, click any node to open that paper.